Article Information
PubMed
Published By
Online ISSN
History
- Received October 26, 2018
- Revision received October 9, 2019
- Accepted October 9, 2019
- Published online November 14, 2019.
Copyright & Usage
© 2019 Owyong et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Mark Owyong1,*,
- Jonathan Chou1,2,5,*,
- Renske JE van den Bijgaart1,
- Niwen Kong1,
- Gizem Efe1,
- Carrie Maynard1,
- Dalit Talmi-Frank6,
- Inna Solomonov6,
- Charlotte Koopman1,
- Elin Hadler-Olsen1,
- Mark Headley3,
- Charlene Lin1,
- Chih-Yang Wang1,
- Irit Sagi6,
- Zena Werb1,5⇑ and
- Vicki Plaks1,4⇑
- 1Department of Anatomy, University of California, San Francisco, CA, USA
- 2Department of Medicine, University of California, San Francisco, CA, USA
- 3Department of Pathology, University of California, San Francisco, CA, USA
- 4Department of Orofacial Sciences, University of California, San Francisco, CA, USA
- 5The Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA
- 6Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
- Correspondence: zena.werb{at}ucsf.edu
- vicki.plaks{at}ucsf.edu
↵* Mark Owyong and Jonathan Chou contributed equally to this work
Funding
National Cancer Institute and the Parker Institute for Cancer Immunotherapy
R01 CA057621 and U01 CA199315; CA180039; CA190851Z WerbCalifornia Breast Cancer Research Program
23IB-001Cancer League
Department of Defense Predoctoral Fellowship
W81XWH-10-1-0168Department of Defense Postdoctoral Fellowship
W81XWH-11-01-0139European Union’s Horizon 2020 Research and Innovation Program
801126; 695437Israel Science Foundation
1800/19USA-Israel Binational Science Foundation
712506-01The Thompson Family Foundation, Inc.
I Sagi
MMP9 in breast cancer anti-metastatic therapy
In this Issue
Advertisement